Actively Recruiting
Tailoring Axillary Surgery for Breast Cancer Based on Tumor Type and Lymph Node Involvement SentiOMIT and SentiMACRO Trials
Led by KK Women's and Children's Hospital · Updated on 2024-02-14
350
Participants Needed
1
Research Sites
43 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring ways to customize axillary surgery for breast cancer patients based on the cancers molecular subtype and the extent of lymph node involvement. The goal is to safely reduce the invasiveness of surgery in early breast cancer cases with favorable molecular features or limited nodal spread, potentially lowering surgery-related complications and costs without affecting cancer outcomes. The study includes two parts Study A SentiOMIT involves 50 patients with early breast cancer of the Luminal A subtype and aims to omit sentinel lymph node biopsy SLNB. Study B SentiMACRO enrolls 300 patients with stage I-II breast cancer who undergo SLNB, then are grouped by nodal status no cancer in lymph nodes pN0, 1-2 metastatic nodes, and 3 or more metastatic nodes. The focus is to see if patients with 1-2 affected nodes can safely avoid full axillary lymph node dissection ALND and only have SLNB. Participants will be monitored for short-term outcomes like surgery-related complications, costs, and operation time up to six months after surgery. Long-term follow-up will assess cancer recurrence and survival over five years. This approach aims to personalize surgery to reduce side effects while maintaining effective cancer control, with total participation extending over several years.
CONDITIONS
Brief Title
Omission of Axillary Surgery in Breast Cancer Patients
Research Team
G
Geok hoon Lim
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here